Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults.

Abstract:

:The p53 tumour suppressor is the central regulator of apoptosis. Previously, the functional TP53 Arg72Pro polymorphism was found to be associated with systemic lupus erythematosus (SLE) in Koreans but not Spaniards. MDM2 is the major negative regulator of p53. An intronic polymorphism in MDM2, the SNP309, attenuates p53 activity and is associated with accelerated tumour development in premenopausal women. Polymorphic variation in MDM2 has never been studied in SLE. The aim of this study is to further assess the contribution of p53-pathway genetic variation to SLE by testing the association of the TP53 Arg72Pro polymorphism and the MDM2 SNP309 with SLE in a well-characterised and ethnically diverse cohort of patients with both childhood- and adult-onset SLE (n = 314). No association was found between the TP53 Arg72Pro polymorphism and SLE in patients of European descent, Asian descent or in African Americans, nor was an association found between the MDM2 SNP309 and SLE in patients of European descent or in African Americans. In addition, there was no correlation between either variant and early-onset disease or nephritis, an index of severe disease. It is concluded that neither the TP53 Arg72Pro polymorphism nor the MDM2 SNP309 contributes significantly to either susceptibility or disease severity in SLE.

journal_name

Lupus

journal_title

Lupus

authors

Onel KB,Huo D,Hastings D,Fryer-Biggs J,Crow MK,Onel K

doi

10.1177/0961203308094558

subject

Has Abstract

pub_date

2009-01-01 00:00:00

pages

61-6

issue

1

eissn

0961-2033

issn

1477-0962

pii

18/1/61

journal_volume

18

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Affinity purified human antiphospholipid antibodies bind normal term placenta.

    abstract::Antiphospholipid antibodies (aPL) are associated with an increased incidence of fetal loss, but the pathophysiology remains unclear. One mechanism may involve the binding of aPL directly to the placenta where they may initiate placental thrombosis and infarction. We have developed an immunofluorescent technique to det...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678840756

    authors: Donohoe S,Kingdom JC,Mackie IJ

    更新日期:1999-01-01 00:00:00

  • Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production.

    abstract::Tumour necrosis factor (TNFalpha) is a cytokine with a wide range of diverse and at times paradoxical effects. These include immunoregulatory, lymphoid organogenesis and pro-inflammatory effects. In recent years, TNFalpha has become a focus of interest more for its inflammatory effects in a number of chronic autoimmun...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu306rr

    authors: Mageed RA,Isenberg DA

    更新日期:2002-01-01 00:00:00

  • Associations between the functional CD40 rs4810485 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.

    abstract:OBJECTIVE:The aim of this study was to determine whether the functional CD40 rs4810485 G/T polymorphism is associated with susceptibility to rheumatoid arthritis (RA) or with susceptibility to systemic lupus erythematosus (SLE). METHODS:A series of meta-analyses were conducted to test for association between the CD40 ...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203315583543

    authors: Lee YH,Bae SC,Choi SJ,Ji JD,Song GG

    更新日期:2015-10-01 00:00:00

  • Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand.

    abstract::Background The prevalence and variation by ethnicity of cutaneous lupus in New Zealand is not known. Therefore, a cross-sectional study to determine the prevalence and variation by ethnicity of cutaneous lupus in the ethnically diverse community of South Auckland, New Zealand, was undertaken. Methods Multiple sources ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316651745

    authors: Jarrett P,Thornley S,Scragg R

    更新日期:2016-11-01 00:00:00

  • Contribution of polymorphism in codon 72 of p53 gene to systemic lupus erythematosus in Poland.

    abstract::The contribution of the p53 Arg72Pro polymorphism in the development of systemic lupus erythematosus (SLE) remains controversial. We investigated the frequency of the p53 Arg72Pro genotype in patients with SLE (n = 155) and in controls (n = 150) in Poland. We found a weak contribution of the Arg/Arg genotype to the mo...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307084722

    authors: Piotrowski P,Lianeri M,Mostowska M,Wudarski M,Chwalinska-Sadowska H,Jagodzinski PP

    更新日期:2008-02-01 00:00:00

  • Infodemiology of systemic lupus erythematous using Google Trends.

    abstract::Objective People affected by chronic rheumatic conditions, such as systemic lupus erythematosus (SLE), frequently rely on the Internet and search engines to look for terms related to their disease and its possible causes, symptoms and treatments. 'Infodemiology' and 'infoveillance' are two recent terms created to desc...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317691372

    authors: Radin M,Sciascia S

    更新日期:2017-07-01 00:00:00

  • Photoprotective habits in children with systemic lupus erythematosus.

    abstract:BACKGROUND:Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can involve multiple organ systems. Exposure to ultraviolet radiation (UVR) can exacerbate pre-existing SLE, and can even induce systemic manifestations. This study aimed to investigate the photoprotective habits of children with SLE and...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320930098

    authors: Janthongsri T,Wisuthsarewong W,Nitiyarom R

    更新日期:2020-07-01 00:00:00

  • Genetic variants in FH are associated with renal histopathologic subtypes of lupus nephritis: a large cohort study from China.

    abstract::Objective Genetic variants in FH (complement factor H) were reported to associate with susceptibility to systemic lupus erythematosus (SLE). This study proposed that the genetic defects of FH in the susceptibility and in the development of lupus nephritis might be different. Methods This study enrolled 334 lupus nephr...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317702254

    authors: Tan M,Hao JB,Chu H,Wang FM,Song D,Zhu L,Yu F,Li YZ,Song Y,Zhao MH

    更新日期:2017-10-01 00:00:00

  • Clinical and immunological pattern and outcome of Egyptian systemic lupus erythematosus patients: a single center experience.

    abstract::Objective The objective of this study was to describe the clinical and immunological pattern and disease outcome in Egyptian systemic lupus erythematosus patients. Patients and methods The medical records of 770 systemic lupus erythematosus patients who were followed from 2002-2015 at Kasr Alainy Hospital, Cairo Unive...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318776085

    authors: Mahmoud GA,Shahin AA,Zayed HS,Moghazy A,Eissa BM

    更新日期:2018-08-01 00:00:00

  • The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus.

    abstract:OBJECTIVES:The objective of this paper is to perform the cross-cultural validation of the French version of the LupusPRO, a disease-targeted patient-reported outcome measure, among systemic lupus erythematosus (SLE) patients in Canada. METHODS:The French version of the LupusPRO and the MOS SF-36 were administered; dem...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314543921

    authors: Bourré-Tessier J,Clarke AE,Kosinski M,Mikolaitis-Preuss RA,Bernatsky S,Block JA,Jolly M

    更新日期:2014-12-01 00:00:00

  • Lupus erythematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus.

    abstract::Skin involvement in systemic lupus erythematosus (SLE) occurs in varied forms. Lupus erythematosus tumidus (LET) is not known to occur with SLE. In our patient presented below, LET occurred in a patient with SLE. Some of the lesions progressed to scarring discoid lesions, while others responded very well to hydoxychlo...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu473cr

    authors: Jolly M,Laumann AE,Shea CR,Utset TO

    更新日期:2004-01-01 00:00:00

  • Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a clinically diverse, complex autoimmune disease which may present with coincident onset of many criteria or slow, gradual symptom accrual. Early intervention has been postulated to delay or prevent the development of more serious sequelae. One option for treatment in this setting...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307078579

    authors: James JA,Kim-Howard XR,Bruner BF,Jonsson MK,McClain MT,Arbuckle MR,Walker C,Dennis GJ,Merrill JT,Harley JB

    更新日期:2007-01-01 00:00:00

  • Digital vasculitis in systemic lupus erythematosus: a minor manifestation of disease activity?

    abstract::The objective of this study is to determine if digital vasculitis (DV), a clinical manifestation with a high systemic lupus erythematosus disease activity index (SLEDAI) score, is associated with lupus severity. DV and other clinical manifestations defined according to the SLEDAI were evaluated in 168 consecutive pati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309106177

    authors: Gomes C,Carvalho JF,Borba EF,Borges CT,Vendramini MB,Bueno C,Costa LP,Bonfá E

    更新日期:2009-10-01 00:00:00

  • Drug-induced subacute cutaneous lupus erythematosus associated with abatacept.

    abstract::Numerous drugs have been linked to the induction or exacerbation of systemic cutaneous lupus erythematosus (SCLE). This report presents the third case of the biologic abatacept as an exacerbating medication for SCLE. A 73-year old woman with a remote history of subacute cutaneous lupus and rheumatoid arthritis, well c...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320981146

    authors: Figueredo Zamora E,Callen JP,Schadt CR

    更新日期:2020-12-22 00:00:00

  • Anti-α-enolase antibody combined with β2 microglobulin evaluated the incidence of nephritis in systemic lupus erythematosus patients.

    abstract:OBJECTIVE:Anti-α-enolase antibody (Ab) combined with β2 microglobulin (β2-MG) were investigated to predict the incidence of nephritis in systemic lupus erythematosus (SLE) patients. METHODS:Levels of serum anti-α-enolase Ab and urinary β2-MG were detected in 115 SLE patients, 29 SLE patients with nephritis and 70 heal...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319828822

    authors: Huang Y,Chen L,Chen K,Huang F,Feng Y,Xu Z,Wang W

    更新日期:2019-03-01 00:00:00

  • AVEMAR (a new benzoquinone-containing natural product) administration interferes with the Th2 response in experimental SLE and promotes amelioration of the disease.

    abstract::The potential of oral treatment with AVEMAR (AVEMAR), a new benzoquinone-containing fermentation product of wheat germ, on features of experimental systemic lupus erythematosus (SLE) in naive mice, induced by idiotypic manipulation, was studied. We assessed the effect of AVEMAR on the profile of autoantibody productio...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301682430203

    authors: Ehrenfeld M,Blank M,Shoenfeld Y,Hidvegi M

    更新日期:2001-01-01 00:00:00

  • Apoptosis in the pathogenesis of systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a prototype inflammatory autoimmune disease resulting from autoimmune responses against nuclear autoantigens. During apoptosis many lupus autoantigens congregate inside the cells and are susceptible to modifications. Modified nuclear constituents are considered foreign and dangero...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308089990

    authors: Munoz LE,van Bavel C,Franz S,Berden J,Herrmann M,van der Vlag J

    更新日期:2008-05-01 00:00:00

  • Lupus nephritis in Croatian children: clinicopathologic findings and outcome.

    abstract::We report clinical and histopathological features, treatment and outcome of 37 Croatian children with biopsy-proven lupus nephritis seen over a 30-year period. The mean age at lupus nephritis presentation was 12.11 ± 2.59 years (range 4.66-17.0). The most frequent histopathological finding was class IV (37.8%), follow...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314563133

    authors: Batinić D,Milošević D,Čorić M,Topalović-Grković M,Jelušić M,Turudić D

    更新日期:2015-03-01 00:00:00

  • Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.

    abstract::The objective of the study was to analyse the prevalence and clinical significance of hypocomplementemia in a large series of patients diagnosed either with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (APS) and its association with the main clinical, hematological and immunological fea...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1080oa

    authors: Ramos-Casals M,Campoamor MT,Chamorro A,Salvador G,Segura S,Botero JC,Yagüe J,Cervera R,Ingelmo M,Font J

    更新日期:2004-01-01 00:00:00

  • Low C4 as a risk factor for severe neuropsychiatric flare in patients with systemic lupus erythematosus.

    abstract:OBJECTIVE:This study aimed to explore the risk factors for 'severe' neuropsychiatric (NP) flare in patients with systemic lupus erythematosus (SLE). METHODS:This retrospective study comprised newly diagnosed 184 adult SLE patients who visited Hokkaido University Hospital between 2006 and 2017. In this study, severe NP...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320938453

    authors: Aso K,Kono M,Kono M,Watanabe T,Shimizu Y,Ogata Y,Fujieda Y,Kato M,Oku K,Amengual O,Yasuda S,Atsumi T

    更新日期:2020-09-01 00:00:00

  • Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).

    abstract:BACKGROUND:Ferritin is an iron storage protein considered also as an acute phase reactant with high levels in various inflammatory conditions. Recently, a plausible role for ferritin in the pathogenesis of immune-mediated and especially autoimmune diseases has been suggested. However, the link between ferritin and the ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313504633

    authors: Agmon-Levin N,Rosário C,Katz BS,Zandman-Goddard G,Meroni P,Cervera R,Stojanovich L,Blank M,Pierangeli S,Praprotnik S,Meis Ed,Seguro LP,Ruffatti A,Pengo V,Tincani A,Doria A,Shoenfeld Y

    更新日期:2013-11-01 00:00:00

  • Legionella pneumophila as a cause of cavitary lung disease in systemic lupus erythematous.

    abstract::Legionnaire's disease (LD) is most commonly caused by Legionella pneumophila (L. pneumophila). In immunocompromised patients LD can cause necrosis of the lung parenchyma with abscess formation and cavitation. Systemic lupus erythematosus (SLE) is an autoimmune disorder with features of both primary and secondary immun...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203321990102

    authors: Khokher W,Kesireddy N,Adunse J,Mudiyanselage PH,Iftikhar S,Assaly R

    更新日期:2021-01-26 00:00:00

  • Elucidation of the potential disease-promoting influence of IgM apoptotic cell-reactive antibodies in lupus.

    abstract::The undigested remnants of apoptosis are believed to stimulate the generation of autoantibodies in lupus. The biological properties of initiator, disease-specific IgM antibodies that specifically recognize apoptotic cells, readily detected in the sera of lupus patients, remain unclear. Apoptotic cell-reactive IgM mono...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315624023

    authors: Malik M,Arora P,Sachdeva R,Sharma L,Ramachandran VG,Pal R

    更新日期:2016-06-01 00:00:00

  • Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus.

    abstract::To assess bladder function in systemic lupus erythematosus (SLE) patients with recurrent urinary tract infections (UTIs). A convenience sample of consecutive patients with SLE (American College of Rheumatology criteria), with recurrent UTIs (>/=3 events in the preceding 12 months), without history of central nervous s...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308093458

    authors: Duran-Barragan S,Ruvalcaba-Naranjo H,Rodriguez-Gutierrez L,Solano-Moreno H,Hernandez-Rios G,Sanchez-Ortiz A,Ramos-Remus C

    更新日期:2008-12-01 00:00:00

  • Outcome criteria for lupus nephritis trials: a critical overview.

    abstract::Lupus nephritis is an important cause of morbidity and mortality in patients with systemic lupus erythematosus. Traditional outcome criteria such as doubling of serum creatinine, end-stage renal disease and death have been used in controlled therapeutic trials, but are limited by their low incidence and the extended p...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920758

    authors: Boumpas DT,Balow JE

    更新日期:1998-01-01 00:00:00

  • Olanzapine-induced neutropenia in a patient with systemiclupus erythematosus: a role of FcγRIIIb polymorphism?

    abstract::In this study, we report the case of a Chinese patient with systemic lupus erythematosus (SLE) who developed neutropenia after treatment by olanzapine for the SLE-related psychiatric symptoms. The relationship between agranulocytosis, SLE and olanzapine is still unknown. Fcγ receptor IIIb (FcγRIIIb) is a low-affinity ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311415889

    authors: Salviati M,Ortona E,Colasanti T,Francia A,Pontecorvo S,Delle Chiaie R

    更新日期:2012-01-01 00:00:00

  • Safety and efficacy of thrombopoeitin mimetics for refractory immune thrombocytopenia purpura in patients with systemic lupus erythematosus or antiphospholipid syndrome: a case series.

    abstract::Background While thrombopoeitin (TPO) agonists that act to simulate platelet production have been approved for use in steroid-refractory chronic immune thrombocytopenia purpura (ITP), there are few data on the safety and efficacy of these medications in patients with concurrent systemic lupus erythematosus (SLE) or an...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318770023

    authors: Lusa A,Carlson A

    更新日期:2018-09-01 00:00:00

  • Vulvar intraepithelial neoplasia in a young woman with systemic lupus erythematosus: a case report.

    abstract::Diagnosing vulvar intraepithelial neoplasia in a young woman presenting mainly with skin manifestations of lupus and with no other risk factors is a major challenge. The case of a 27-year-old woman with systemic lupus erythematosus and vulvar intraepithelial neoplasia is described. Although progression of vulvar intra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309345742

    authors: Stepanić V,Corusić A,Matković V,Sentić M,Bosnić D,Mahovlić V

    更新日期:2010-01-01 00:00:00

  • High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is an immune-mediated disease that is responsive to suppression or modulation of the immune system. Patients with SLE who experience persistent multiorgan dysfunction, despite standard doses of intravenous cyclophosphamide (Cy), represent a subset of patients at high risk of early de...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu491oa

    authors: Lisukov IA,Sizikova SA,Kulagin AD,Kruchkova IV,Gilevich AV,Konenkova LP,Zonova EV,Chernykh ER,Leplina OY,Sentyakova TN,Demin AA,Kozlov VA

    更新日期:2004-01-01 00:00:00

  • Early-stage predictors for treatment responses in patients with active lupus nephritis.

    abstract:OBJECTIVE:We analyzed data of lupus nephritis (LN) patients to find parameters that can predict remission. METHODS:Sixty-four LN patients who were diagnosed with class III, IV, V or V + III/IV by renal biopsy and were followed up for more than six months in our center were enrolled retrospectively. Receiver operating ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319826703

    authors: Liu G,Wang H,Le J,Lan L,Xu Y,Yang Y,Chen J,Han F

    更新日期:2019-03-01 00:00:00